Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of Four H. pylori Regimens in Chinese Children
NCT03365609Recruiting
- Start
- Sep 2017
- Primary completion
- Oct 2025
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
Randomised, open-label trial of omeprazole, amoxicillin, clarithromycin, metronidazole and bismuth subcitrate in Helicobacter pylori infection (4 arms). Primary endpoint: H. pylori eradication rate. Started Sep 2017; status: recruiting.
02
Drugs
omeprazoleamoxicillinclarithromycinmetronidazolebismuth subcitrate
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on NCT03365609.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03365609.